Research on PKM2 is an active field, with studies focusing on its structural biology, regulation, and function in cancer. Efforts are being made to develop specific inhibitors and activators of PKM2, as well as to understand its interactions with other metabolic and signaling pathways. Advances in proteomics and metabolomics are also providing deeper insights into the role of PKM2 in cancer and its potential as a therapeutic target.
